Search - tctmd.com

Displaying 101 - 103 of 103

Sort: Relevancy | Date

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

September 16, 2019

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

News Daily News

Digging In: Adherence to Plant-Based Diets Linked to Fewer HF Hospitalizations

April 23, 2019

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.